Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 5/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.61 |
| ▸ | RAB9A | P51151 | 4/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.61 |
| ▸ | NPC1 | O15118 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CA7 | P43166 | 1/20 | 0.49 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24576001 | 0.86 | MEN1 (0.63) | ALDH1A1L3MBTL1MEN1KMT2ARAB9A | |
| SCHEMBL23235888 | 0.85 | CYP1A2 (0.51) | ALDH1A1L3MBTL1MEN1KMT2ARAB9A | |
| SCHEMBL13104785 | 0.85 | RAB9A (0.61) | ALDH1A1L3MBTL1MEN1KMT2ARAB9A | |
| SCHEMBL5933554 | 0.85 | MEN1 (0.61) | ALDH1A1L3MBTL1MEN1KMT2ARAB9A | |
| SCHEMBL11533429 | 0.83 | CYP2C9 (0.65) | ALDH1A1MEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL13169668 | 0.83 | ERCC1 (0.60) | ALDH1A1L3MBTL1MEN1KMT2ARAB9A | |
| SCHEMBL5932415 | 0.83 | MEN1 (0.59) | ALDH1A1L3MBTL1MEN1KMT2ARAB9A | |
| SCHEMBL9272879 | 0.83 | CYP2C9 (0.65) | ALDH1A1L3MBTL1MEN1KMT2ARAB9A | |
| SCHEMBL5932406 | 0.83 | MEN1 (0.59) | ALDH1A1L3MBTL1MEN1KMT2ARAB9A | |
| SCHEMBL13652539 | 0.81 | ALDH1A1 (0.63) | ALDH1A1L3MBTL1MEN1KMT2ARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3756666-A1 | NICOTINAMIDE COMPOUND FOR USE IN THE TREATMENT OF CANCER | Oncotartis Inc. (US) | 2020-12-30 | — | — | EP | disclosed |
| EP-3087051-B1 | BENZAMIDE AND NICOTINAMIDE COMPOUNDS AND METHODS OF USING SAME | ONCOTARTIS INC (US) | 2020-07-15 | — | — | EP | disclosed |
| US-9028590-B2 | Process and apparatus for carbon dioxide and carbonyl sulfide capture via ion exchange resins | LANXESS DEUTSCHLAND GMBH (US) | 2015-05-12 | — | — | US | disclosed |
| EP-2490789-B1 | PROCESS FOR CARBON DIOXIDE CAPTURE VIA ION EXCHANGE RESINS | LANXESS SYBRON CHEMICALS INC (US) | 2014-08-06 | — | — | EP | disclosed |
| US-20130193378-A1 | PROCESS AND APPARATUS FOR CARBON DIOXIDE AND CARBONYL SULFIDE CAPTURE VIA ION EXCHANGE RESINS | LANXESS DEUTSCHLAND GMBH (DE) | 2013-08-01 | — | — | US | disclosed |
| US-8414689-B2 | Process and apparatus for carbon dioxide capture via ion exchange resins | LANXESS SYBRON CHEMICALS INC. (US) | 2013-04-09 | — | — | US | disclosed |
| US-20120228553-A1 | PROCESS AND APPARATUS FOR CARBON DIOXIDE CAPTURE VIA ION EXCHANGE RESINS | LANXESS SYBRON CHEMICALS INC. (US) | 2012-09-13 | — | — | US | disclosed |
| WO-2011049759-A1 | PROCESS AND APPARATUS FOR CARBON DIOXIDE CAPTURE VIA ION EXCHANGE RESINS | LANXESS SYBRON CHEMICALS, INC. (US) | 2011-04-28 | — | — | WO | disclosed |
| US-20110088550-A1 | PROCESS AND APPARATUS FOR CARBON DIOXIDE CAPTURE VIA ION EXCHANGE RESINS | LANXESS SYBRON CHEMICALS INC. (US) | 2011-04-21 | — | — | US | disclosed |
| US-7671072-B2 | Aminopyrazole derivatives as GSK-3 inhibitors | PFIZER INC. (US) | 2010-03-02 | — | — | US | disclosed |
| US-20070276010-A1 | Aminopyrazole Derivatives as Gsk-3 Inhibitors | BENBOW JOHN W | 2007-11-29 | — | — | US | disclosed |
| US-20060088786-A1 | Rewritable optical information recording medium, recording and reproducing methods, as well as recording and reproducing apparatus | MITSUI CHEMICALS, INC. (JP) | 2006-04-27 | — | — | US | disclosed |
| EP-1484191-A1 | REWRITABLE OPTICAL INFORMATION RECORDING MEDIUM AND RECORDING/REPRODUCING METHOD, RECORDING/REPRODUCING DEVICE | Sony Corporation (JP) | 2004-12-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130193378-A1 | PROCESS AND APPARATUS FOR CARBON DIOXIDE AND CARBONYL SULFIDE CAPTURE VIA ION EXCHANGE RESINS | CBR3, CBR1, CBS | ALDH1A1 1464/4885L3MBTL1 4305/4885MEN1 4314/4885 |
| US-20070276010-A1 | Aminopyrazole Derivatives as Gsk-3 Inhibitors | GSK3B, GSK3A, GSKIP | ALDH1A1 1036/4885L3MBTL1 1447/4885MEN1 2015/4885 |
| US-20060088786-A1 | Rewritable optical information recording medium, recording and reproducing methods, as well as recording and reproducing apparatus | ALPG, TRPC6, GNRHR | ALDH1A1 2071/4885L3MBTL1 1083/4885MEN1 1357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.